Adaptive Deep Brain Stimulation: A Personalized Breakthrough for Parkinson’s Patients

Adaptive deep brain stimulation cuts Parkinson’s symptoms in half. Read how personalized DBS works and its real-world impact on patients like skateboarder Shawn Connolly.

From Skateboarder to Research Pioneer

When Shawn Connolly was diagnosed with Parkinson’s at age 39, his skateboarding skills rapidly declined. Involuntary hand movements and balance issues made everyday life a struggle. Traditional treatments offered limited relief, so he enrolled in a landmark study of adaptive deep brain stimulation (aDBS). The system reduced his most severe symptoms by half, giving him longer windows of normal function. Today, Connolly runs a skateboard program for children, carrying on a legacy he built with his late wife, Thuy Nguyen.

How Adaptive DBS Adjusts in Real Time

Published in Nature Medicine, the University of California, San Francisco (UCSF)-led trial introduces a personalized aDBS system. Unlike conventional DBS, which delivers constant stimulation, this system uses a real-time algorithm that adjusts electrical pulses based on each patient’s brain signals. It specifically targets signals linked to slowness of movement (bradykinesia) and uncontrolled movements (dyskinesia). The result is fewer and less severe symptoms, significantly improving quality of life.

Real‑World Freedom

Earlier studies were confined to lab settings, but this one let participants live normally—skateboarding, traveling, and exercising. Wearable monitors tracked movements, and daily questionnaires measured outcomes. The data showed a clear reduction in symptom burden. Connolly could tell when adaptive stimulation was active versus conventional; he felt sluggish with the latter.

Expanding Beyond Parkinson’s

The success of personalized DBS opens possibilities for other neurological and psychiatric conditions. Early experiments show promise for depression, obsessive-compulsive disorder (OCD), and chronic pain. As Dr. Jaimie Henderson of Stanford University notes, personalized stimulation is likely the future of neurological treatments. Advances in AI and wearable tech make it possible to refine algorithms continuously as patients’ conditions evolve.

Remaining Hurdles

Developing personalized algorithms remains time-consuming. The first patient required two years to devise an effective algorithm, but by the fourth patient that time dropped to two weeks. Frequent adjustments are needed as symptoms and medications change. Accessibility and cost are also barriers; widespread adoption will require making the technology more affordable. Researchers and healthcare providers must collaborate on scalable solutions.

What’s Next for Adaptive Brain Stimulation

With ongoing research and improvements in AI, brain pacemakers tailored to individual needs could become standard within a decade. The time needed to develop personalized plans will likely shrink further. For millions of patients worldwide, this adaptive approach offers new hope—not just for managing symptoms, but for living fuller, more active lives.